Verrica Pharmaceuticals (VRCA) Q1 2025 Earnings

11MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.49
-0.41
-0.32
-0.24

Details

Expected EPS
-0.25
Actual EPS
-0.24
Surprise EPS
0.01
Surprise Percent
+4%

Description

Verrica Pharmaceuticals (VRCA) has reported earnings of -0.24 per share for Q1 2025.

0 Comments

Share your thoughts